Melanie Galadzhyan
Gerontology · West Hills, CANPI 1598410201
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations.
Across 82 payments — averaging $25.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$214
- Incyte Corporation$165
- Johnson & Johnson$165
- Seagen Inc.$116
- Karyopharm Therapeutics Inc.$98
- Novartis$94
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,120100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 8 | $214 |
| Incyte Corporation | 6 | $165 |
| Johnson & Johnson | 6 | $165 |
| Seagen Inc. | 5 | $116 |
| Karyopharm Therapeutics Inc. | 3 | $98 |
| Novartis | 4 | $94 |
| Pharmaessentia USA Corporation | 3 | $90 |
| Pharmacosmos Therapeutics Inc. | 3 | $79 |
| Jazz Pharmaceuticals Inc. | 3 | $76 |
| Bayer | 3 | $74 |
| Merck | 3 | $71 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Genentech USA, Inc. | 2 | $64 |
| ADC Therapeutics America, Inc. | 2 | $63 |
| Tempus AI, Inc | 3 | $58 |
| Sobi, Inc | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| G1 Therapeutics, Inc. | 2 | $48 |
| Pfizer | 2 | $44 |
| Bristol Myers Squibb | 2 | $44 |
| Novocure Inc. | 1 | $38 |
| Eisai Inc. | 2 | $38 |
| Immunocore Limited | 1 | $35 |
| Astellas Pharma US Inc | 1 | $33 |
| Taiho Oncology, Inc. | 1 | $29 |
| GSK | 1 | $29 |
| Immunogen, Inc. | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $28 |
| Sun Pharmaceutical Industries Inc. | 1 | $26 |
| Puma Biotechnology, Inc. | 1 | $25 |
| AVEO Pharmaceuticals, Inc. | 1 | $21 |
| Mirati Therapeutics, Inc. | 1 | $20 |
| Tolmar Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$2,120 in reported general payments places this provider in the 85th percentile of 348 gerontology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProcritEpoetin Alfa | 15 | $62,702 |
| EliquisApixaban | 36 | $44,335 |
| XareltoRivaroxaban | 31 | $30,215 |
| OzempicSemaglutide | 25 | $22,885 |
| Teriparatide | 12 | $21,362 |
| MounjaroTirzepatide | 11 | $11,428 |
| Anastrozole | 80 | $1,758 |
| Letrozole | 29 | $1,388 |
| Ondansetron OdtOndansetron | 44 | $804 |
| Pantoprazole Sodium | 87 | $657 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $648 |
| Acyclovir | 29 | $634 |
| Dexamethasone | 45 | $564 |
| Hydroxyzine Hcl | 11 | $405 |
| Potassium Chloride | 17 | $393 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonProcrit, Xarelto | $165 | $92,91746 claims |
| PfizerEliquis | $44 | $44,33536 claims |
| Lilly USA, LLCMounjaro, Olanzapine | $13 | $11,65526 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 348 gerontology providers in California.
Other gerontology in West Hills
- Lovely IsraelSanta Monica$95K
- Leslie TarlowLos Angeles$58K
- Christine PartamianPorter Ranch$41K
- Elsa Pineda-FloresLos Angeles$24K
- Maria MottaDuarte$23K
- Daniel ChiuOrange$17K
- Katiaryna KulinichChula Vista$15K
- Nataliya OsorioRiverside$13K
- Anne Marie de Joya ReeveDuarte$11K
- Wendy AlmonteLemoore$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.